Navigation Links
Patient Monitoring Devices Market to 2017 - Increasing Use of Wireless Remote Patient Monitoring to be the Key Technology Trend
Date:6/28/2012

home, Product Status, 2011 98

Table 58: BTT Wireless Device, Product Status, 2011 99

Table 59: Next Generation LifeShirt System, Product Status, 2011 99

Table 60: VigilCare, Product Status, 2011 99

Table 61: Medical Kiosk, Product Status, 2011 100

Table 62: Remote Patient Monitoring, Global Pipeline Products, 2011 - Table 1 100

Table 63: Remote Patient Monitoring, Global Pipeline Products, 2011 - Table 2 101

Table 64: Power-Free Implantable Blood Pressure Sensor, Product Status, 2011 102

Table 65: Care Taker - Blood Pressure Monitor, Product Status, 2011 103

Table 66: Mespere Venus Monitor, Product Status, 2011 103

Table 67: Blood Pressure Monitor, Product Status, 2011 104

Table 68: Implantable Blood Pressure Sensor, Product Status, 2011 104

Table 69: Non-Invasive Blood Pressure Monitors, Global Pipeline Products, 2011 105

Table 70: Blink System, Product Status, 2011 106

Table 71: icuPATCH, Product Status, 2011 106

Table 72: ISMO, Product Status, 2011 107

Table 73: Proxima System, Product Status, 2011 107

Table 74: LTM/iRevive System, Product Status, 2011 108

Table 75: Portable Microwave Sensor, Product Status, 2011 108

Table 76: HemoPod, Product Status, 2011 109

Table 77: Closed-Loop Neonatal Oxygen Control, Product Status, 2011 109

Table 78: Decompression Sickness Monitor, Product Status, 2011 110

Table 79: Nemo Patch, Product Status, 2011 110

Table 80: Nemo System, Product Status, 2011 111

Table 81: PD2i-VS, Product Status, 2011 111

Table 82: UFIT, Product Status, 2011 111

Table 83: URINFO 3000, Product Status, 2011 112

Table 84: Home-Based Blood Pressure Measuring Device, Product Status, 2011 112

Table 85: Personal Cardiovascular Monitor, Product Status, 2011 113

Table 86: Wearable Blood Pressure Monitor, Product Status, 2011 113

Table 87: Multiparamter Pa
'/>"/>

SOURCE Reportlinker
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16

Related medicine technology :

1. Study Showed Patients Treated With The miraDry© System Experienced 82 Percent Sweat Reduction On Average
2. Argos Therapeutics Secures $25 million Series D Financing to Commence Phase 3 ADAPT Study in Patients with Metastatic Renal Cell Carcinoma (mRCC) in Mid-2012
3. Watching, Reading and Listening: A New Way to Interact with Patient Information
4. Phreesia identifies over 26% of patients who require additional autism evaluation
5. Anthera Announces the Completion of Patient Dosing in Phase 2b PEARL-SC Study
6. Almost 50 Percent of the Glaucoma Patient Population Remains Untreated, Signifying a Vast Market for Glaucoma Pharmaceuticals, Finds Frost & Sullivan
7. Onyx Pharmaceuticals Announces FDA Advisory Committee to Review Carfilzomib for the Treatment of Patients with Relapsed and Refractory Multiple Myeloma
8. New post-hoc analyses examined Neupro® effects on pain, depressed mood, apathy and fatigue in patients with Parkinsons disease
9. Patient Advocate Foundation Announces New Co-Pay Relief (CPR) Offerings for Patients Facing Health Issues Due to Electrolyte Imbalance
10. Quest Diagnostics Establishes Unique Healthcare Identifier to Improve Access to Vital Patient Health Information; 80 Million Patient IDs Created to Date
11. Retrospective Study Suggests that Stereotactic Ablative Radiotherapy (SABR) Can be a Viable Option for Treating Early-Stage Lung Cancer in Operable as well as Inoperable Patients; Phase III Randomized Trial Now Under Way
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/22/2014)... 22, 2014 Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX) ... financial results after the market closes on Tuesday, August ... will be held on Tuesday, August 5, 2014, at ... To participate in the call, please dial 877-303-1298 ... rebroadcast of the teleconference will be available for one ...
(Date:7/22/2014)... July 22, 2014 Legislation backed by ... to Local Pharmacies Act of 2014") championing so-called ... would undermine the availability of lower cost preferred ... billion over the next 10 years, according to ... the Pharmaceutical Care Management Association (PCMA). ...
(Date:7/22/2014)... Pa. , July 22, 2014  Eyeon Therapeutics ... dry eye treatment based on a charged hydrophilic polymer ... The product has been shown to be safe and ... Mitchnick , MD, CEO states, "This first set of ... a long way to moving this technology into the ...
Breaking Medicine Technology:Cumberland Pharmaceuticals To Announce Second Quarter 2014 Financial Results On August 5, 2014 2New Study: H.R. 4577 to Cost $21 Billion over 10 Years 2New Study: H.R. 4577 to Cost $21 Billion over 10 Years 3Particle Sciences and Eyeon Therapeutics Receive Patent on Novel Dry Eye Technology 2
... Mass., Dec. 15, 2011  For parents, knowing how to take ... like sweat or drafts affect the accuracy of results can ... Vicks ® Behind ... out of measuring for fever, restoring confidence to parents and ...
... 2011   Enlight Biosciences LLC announced today ... and Novo Nordisk.  As partners in Enlight, AstraZeneca and ... and invest in the development of potentially transformational ... was created by PureTech Ventures in partnership with ...
Cached Medicine Technology:Behind The Ear -- A New Site To Measure for Fever 2Behind The Ear -- A New Site To Measure for Fever 3Enlight Biosciences Forms New Partnerships with AstraZeneca and Novo Nordisk 2Enlight Biosciences Forms New Partnerships with AstraZeneca and Novo Nordisk 3
(Date:7/22/2014)... of Hematology (ASH) will present the Society,s highest honor, ... in Hematology, to Kanti R. Rai, MD, of the ... for his 50-year career combining landmark clinical leukemia research, ... care. , The Wallace H. Coulter Award for ... who has been a vital contributor to the field ...
(Date:7/22/2014)... Washington DC (PRWEB) July 22, 2014 ... in USA, launched updated payment app for Forte Payment ... credit, debit and ACH payments on iPhone, iPod and ... 2013 and has been recently updated by SIMpalm. This ... support; app is currently supported on iOS 4.3 and ...
(Date:7/22/2014)... American Conference on Lung Cancer (LALCA 2014) will be ... , Lung Cancer is still the leading cause of ... on the success of the previous conferences in Chile, ... discuss the science and advances in the treatment and ... Latin America in particular. , With tobacco being the ...
(Date:7/22/2014)... The Pennsylvania judge overseeing hundreds ... in the Philadelphia Court of Common Pleas won’t ... cases alleging the medication caused plaintiffs to develop ... In an Order dated July 18, 2014, Judge ... certify the matter for an immediate appeal to ...
(Date:7/22/2014)... The market for botulinum neurotoxin (BoNT) ... owing to novel medical indications created and due to ... societies where physical appearance is extremely valued. Although the ... competitors, new companies and technologies are setting ground for ... put the price of 1st-gen products under pressure, only ...
Breaking Medicine News(10 mins):Health News:ASH honors Kanti R. Rai, M.D., with Coulter Award for Lifetime Achievement 2Health News:ASH honors Kanti R. Rai, M.D., with Coulter Award for Lifetime Achievement 3Health News:ASH honors Kanti R. Rai, M.D., with Coulter Award for Lifetime Achievement 4Health News:SIMpalm Launched Updated Forte Mobile Payment App on iPhone and iPad for Its Client 2Health News:SIMpalm Launched Updated Forte Mobile Payment App on iPhone and iPad for Its Client 3Health News:Risperdal Lawsuit News: Pennsylvania Judge Won’t Reconsider Denial of Punitive Damages for Risperdal Gynecomastia Plaintiffs, Bernstein Liebhard LLP Reports 2Health News:Risperdal Lawsuit News: Pennsylvania Judge Won’t Reconsider Denial of Punitive Damages for Risperdal Gynecomastia Plaintiffs, Bernstein Liebhard LLP Reports 3Health News:Risperdal Lawsuit News: Pennsylvania Judge Won’t Reconsider Denial of Punitive Damages for Risperdal Gynecomastia Plaintiffs, Bernstein Liebhard LLP Reports 4Health News:Botulinum Neurotoxins Marketplace Analysed in New La Merie Publishing Report Available at MarketPublishers.com 2Health News:Botulinum Neurotoxins Marketplace Analysed in New La Merie Publishing Report Available at MarketPublishers.com 3Health News:Botulinum Neurotoxins Marketplace Analysed in New La Merie Publishing Report Available at MarketPublishers.com 4
... Annual Meeting & OTO EXPO of the American Academy of ... meeting of ear, nose, and throat doctors in the world, ... more than 305 scientific research sessions, 594 posters, and several ... a unique opportunity for journalists from around the world to ...
... graduate student Brian Zikmund-Fisher was forced into the toughest choice ... few years or endure a bone marrow transplant that could ... now an assistant professor at the University of Michigan School ... After nine months of blood transfusions, a bone marrow match ...
... By Dennis Thompson HealthDay Reporter , TUESDAY, ... smile. What wasn,t to like about a break in the ... and fun? Now fast-forward to your adult life. What ... Some medical experts think it,s not only a good idea ...
... to indicate a racial disparity in the psychological abuse ... African American seniors could be twice as likely to ... also revealed that African American elders could be up ... the survey results in The Gerontologist, the ...
... there may be a way to predict, based on individual ... the investigational new drug tivozanib. This is possible, the ... a new way of creating animal tumor models that mimic ... these studies, they have found a single biomarker that may ...
... Jewish Health has received a US patent for a ... bubble to deliver an antigen and DNA adjuvant. Chairman ... Health Professor of Medicine Steve Dow, PhD, developed the ... of an infectious organism, generally work fine by themselves. ...
Cached Medicine News:Health News:2010 AAO-HNSF miniseminars: Wednesday, Sept. 29, 2010 2Health News:2010 AAO-HNSF miniseminars: Wednesday, Sept. 29, 2010 3Health News:Doctors need to help patients prepare better for health decisions 2Health News:Doctors need to help patients prepare better for health decisions 3Health News:Adding Recess to the Workday Gains Backers 2Health News:Adding Recess to the Workday Gains Backers 3Health News:Adding Recess to the Workday Gains Backers 4Health News:African-American seniors at twice the risk for mental abuse, 5 times for financial exploitation 2Health News:African-American seniors at twice the risk for mental abuse, 5 times for financial exploitation 3Health News:Novel biomarker may predict response to new VEGF receptor inhibitor 2
For support, strength and control in your interventions, the RunWay Guide Catheter's large lumen and high-performance design represents a new era in guide catheters....
For support, strength and control in your interventions, the RunWay Guide Catheter's large lumen and high-performance design represents a new era in guide catheters....
... 20-year history, the VOYAGER RX Dilatation Catheter ... outcomes. It combines a new low profile, ... shaft,more flexible markers, and short taper balloon ... tortuous anatomy with even greater confidence, opening ...
... developed over Guidants 20-year history, the VOYAGER ... for successful treatment outcomes. It combines a ... a lower profile shaft,more flexible markers, and ... cross tight and tortuous anatomy with even ...
Medicine Products: